Call for Speaker Proposals
제2회
Oncology Clinical Trials
-암치료제 임상시험 학회-
임상시험의 개선에 의한 암치료제 개발의 촉진
2월 21일∼23일
최근 암분자생물학 연구의 눈부신 성과로 인해 암치료제 개발 분야에서는 전례없이 많은 새로운 표적이 생성되고 있습니다. 이와 같은 표적 대상 약제의 다 수는 이미 임상 단계로 진행되고 있으며, 다양한 치료법을 위한 암치료제의 임상시험이 활발히 진행되고 있습니다. 암치료제의 임상시험을 성공시키기 위한 요인은 많이 있으나, 가장 중요한 요인은 임상전 데이터가 검증가능한 가설을 도출하는 것이 가능한 수준에 도달했는가라는 점입니다. 또한 생물통계학, 과 학, 조직, 규제, 윤리, 경제 등에 관련된 요인도 의약품의 임상개발을 진행시키는데 중요한 의미를 지니고 있습니다.
Who should attend: Scientists, biostatisticians, project managers, research investigators and other specialists involved in oncology clinical trials
Topics will include, but are not limited to:
- Translational clinical trials in oncology
- Evaluating pre-clinical evidence to avoid clinical development failures
- Molecular imaging in cancer clinical trials
- Prescreening patients for somatic mutations before randomization
- Biomarker-driven clinical trials
- Companion diagnostics in oncology clinical trials
- Advanced methodology for dose-finding clinical trials
- Dose finding for “nontoxic” drug
- Pharmacodynamic biomarkers and their use in clinical trials
- Role of randomization in middle development
- How to use surrogate outcomes in the light of lack of biomarker validation
- Regulatory and legal challenges and solutions
- Safety issues in cancer clinical trials
- Ways to increase patient enrollment
- Ethical issues related to biomarker use for patient selection (what is the threshold?)
- Cost effectiveness of clinical trials in the US and abroad
- Joint development: Industry-academic collaboration (identification (who takes responsibility), shared intellectual property, etc.)
The deadline for submission is July 29, 2011.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are
offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
